Literature DB >> 21056138

Extracellular pressure stimulates adhesion of sarcoma cells via activation of focal adhesion kinase and Akt.

Brandon C Perry1, Shouye Wang, Marc D Basson.   

Abstract

BACKGROUND: The effect of extracellular pressure on adhesion and adhesiogenic focal adhesion kinase (FAK) and Akt signaling in sarcomas was investigated.
METHODS: Human sarcoma cells (HT-1080 fibrosarcoma, KHOS-240S osteosarcoma, and A-673 rhabdomyosarcoma) were subjected to increased pressure followed by adhesion assay. Two cell lines were pretreated with the FAK inhibitor 1,2,4,5-benzenetetraamine tetrahydrochloride (Y15) or Akt IV inhibitor, followed by Western analysis for activated FAK and Akt. Parallel studies were conducted in cells from a resected human fibrous histiosarcoma.
RESULTS: Pressure increased adhesion in all 3 sarcoma lines and primary histosarcoma cells by 7% to 18% (n = 6; P < .01 each). Pressure activated FAK and Akt (n = 5; P < .01). Inhibiting FAK or Akt inhibited FAK or Akt phosphorylation and the stimulation of adhesion by increased pressure (n = 5 each; P < .01 each).
CONCLUSIONS: Pressure increases sarcoma cell adhesiveness via Akt and FAK. Perioperative manipulation or forces in lymphatic or circulatory systems may potentiate local recurrence or distant metastasis. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056138      PMCID: PMC3837573          DOI: 10.1016/j.amjsurg.2010.07.013

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  25 in total

Review 1.  Cadherin-mediated cellular signaling.

Authors:  Margaret J Wheelock; Keith R Johnson
Journal:  Curr Opin Cell Biol       Date:  2003-10       Impact factor: 8.382

2.  Shear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin alphavbeta3.

Authors:  Karen Lawler; Gerardene Meade; Gerald O'Sullivan; Dermot Kenny
Journal:  Am J Physiol Cell Physiol       Date:  2004-07-07       Impact factor: 4.249

3.  Implantation of colon cancer at trocar sites is increased by low pressure pneumoperitoneum.

Authors:  J S Wu; E B Brasfield; L W Guo; M Ruiz; J M Connett; G W Philpott; D B Jones; J W Fleshman
Journal:  Surgery       Date:  1997-07       Impact factor: 3.982

Review 4.  Synthesis and function of 3-phosphorylated inositol lipids.

Authors:  B Vanhaesebroeck; S J Leevers; K Ahmadi; J Timms; R Katso; P C Driscoll; R Woscholski; P J Parker; M D Waterfield
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

5.  Effects of increased ambient pressure on colon cancer cell adhesion.

Authors:  M D Basson; C F Yu; O Herden-Kirchoff; M Ellermeier; M A Sanders; R C Merrell; B E Sumpio
Journal:  J Cell Biochem       Date:  2000-04       Impact factor: 4.429

6.  FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway.

Authors:  Vijayalakshmi Thamilselvan; David H Craig; Marc D Basson
Journal:  FASEB J       Date:  2007-02-22       Impact factor: 5.191

7.  Colon cancer cell adhesion in response to Src kinase activation and actin-cytoskeleton by non-laminar shear stress.

Authors:  Vijayalakshmi Thamilselvan; Ashish Patel; Jochem van der Voort van Zyp; Marc D Basson
Journal:  J Cell Biochem       Date:  2004-05-15       Impact factor: 4.429

8.  Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis.

Authors:  Christian Recher; Loïc Ysebaert; Odile Beyne-Rauzy; Véronique Mansat-De Mas; Jean-Bernard Ruidavets; Pascal Cariven; Cécile Demur; Bernard Payrastre; Guy Laurent; Claire Racaud-Sultan
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

9.  Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study.

Authors:  Afshin Dowlati; Robert Gray; Alan B Sandler; Joan H Schiller; David H Johnson
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

10.  Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signaling.

Authors:  Vijayalakshmi Thamilselvan; Marc D Basson
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

View more
  7 in total

1.  ZINC4085554 inhibits cancer cell adhesion by interfering with the interaction of Akt1 and FAK.

Authors:  Shyam K More; Emilie E Vomhof-Dekrey; Marc D Basson
Journal:  Oncol Lett       Date:  2019-03-27       Impact factor: 2.967

2.  Letter to the Editor: Pearls: The Mobile Segment in Sarcoma Resections.

Authors:  Hong-Bo He; Yi-He Hu; Jun Wan
Journal:  Clin Orthop Relat Res       Date:  2018-04       Impact factor: 4.176

3.  Reply to the Letter to the Editor: Pearls: The Mobile Segment in Sarcoma Resections.

Authors:  R Lor Randall
Journal:  Clin Orthop Relat Res       Date:  2018-04       Impact factor: 4.176

Review 4.  Moving beyond VEGF for anti-angiogenesis strategies in gynecologic cancer.

Authors:  Duangmani Thanapprapasr; Wei Hu; Anil K Sood; Robert L Coleman
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 5.  Targeting focal adhesion kinase in neuroblastoma.

Authors:  Lauren Gillory; Elizabeth A Beierle
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

6.  Inhibition of pressure-activated cancer cell adhesion by FAK-derived peptides.

Authors:  Bixi Zeng; Dinesh Devadoss; Shouye Wang; Emilie E Vomhof-DeKrey; Leslie A Kuhn; Marc D Basson
Journal:  Oncotarget       Date:  2017-08-24

7.  Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells.

Authors:  Alicia M Waters; Laura L Stafman; Evan F Garner; Smitha Mruthyunjayappa; Jerry E Stewart; Elizabeth Mroczek-Musulman; Elizabeth A Beierle
Journal:  Transl Oncol       Date:  2016-06-24       Impact factor: 4.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.